J Korean Med Assoc.  2009 May;52(5):518-524. 10.5124/jkma.2009.52.5.518.

Current Pharmacotherapy of Depression

• Ham BJ
• Jung IK

• KMID: 2188020
• DOI: http://doi.org/10.5124/jkma.2009.52.5.518

Abstract

Currently, pharmacotherapy is the primary treatment modality for depression. Various classes of antidepressants have been developed and are widely used at present. Although the antidepressant effects of these drugs are thought to be similar, there are numerous differences between drugs in pharmacologic characteristics, side effects, and tolerabilities. Furthermore, 40~50% of patients may not respond sufficiently to the first-line antidepressants they take. As the response rates are substantially insufficient, and the side effects are not uncommon, the optimal treatment of antidepressants is somewhat difficult. Therefore, the clinicians treating depression should understand the characteristics of various antidepressants and also the optimal treatment strategy. In this review, we introduce various antidepressants and optimal treatment strategies for the treatment of depression.

Keyword

Depression; Pharmacotherapy; Antidepressants

MeSH Terms

Antidepressive Agents
Depression
Humans
Antidepressive Agents

Reference

1. Ham BJ, Han CH. Optimising Antidepressant Use in Clinical Practice: Considering External Factors. J Korean Neuropsychiatr Assoc. 2008. 47:22–27.

2. Kang RH, Kim SY, Lee MS. Korean Clinical Practice Guideline for the Treatment of Depressive Disorder (II). J Korean Soc Biol Psychiatry. 2006. 13:219–225.

3. Mann JJ. The medical management of depression. N Engl J Med. 2005. 353:1819–1834.

4. Stahl SM. Essential psychopharmacology of depression and bipolar disorder. 2008. 3rd edition. New York: Cambridge University Press;68–124.

5. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Marcio V, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry. 2007. 8:67–104.